Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.4.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.6.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.6.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.48EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.48EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EK.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EK.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.66EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.66EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.39EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.39EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EE.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EE.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ES.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ES.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.41EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.41EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.495EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.495EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.294EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.294EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.453EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.453EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.350EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.350EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.304EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.304EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.177EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.177EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.301EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.301EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.308EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.308EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.210EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.210EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.325EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.325EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.590EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used